ONCOLOGY REPORTS-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2222846, encodeId=b6e32222846b5, content=这个杂志我以后不会再投了，前面问你伦理的处理方式，也提供了伦理审查书，包括如何安乐死动物、也没提什么关于伦理的问题，都接收了，快一个月的时候，问你安乐死是符合美国、欧洲、和英国的哪个国家的标准。我写了美国的标准。然后就给拒了，说用异氟烷过量吸入麻醉是不被允许的。你要拒早拒，浪费别人大量的时间, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=286f9158919, createdName=ms6000001003421086, createdTime=Wed Aug 28 15:59:19 CST 2024, time=2024-08-28, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2214074, encodeId=632f22140e45c, content=求问，这个杂志能投case report吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8fe96448100, createdName=ms3000000420360328, createdTime=Tue Jul 09 14:04:30 CST 2024, time=2024-07-09, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2142538, encodeId=f22b214253881, content=投稿命中率:50.0 经验分享：这个杂志的Under review 和Under Review有区别吗，是不是前者是编辑在审后者是外审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=305b1652988, createdName=ms00020231314666, createdTime=Tue Jun 13 10:24:26 CST 2023, time=2023-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=814734, encodeId=cb32814e3446, content=我的文章7.13号under review,现在已经8.29了，突然看见action位置提示replace files，邮箱里找了个遍也没看到通知修改的邮件，大家有知道是什么状况的吗？我都有些毛了，我找了垃圾箱也没有啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=191, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a1921902389, createdName=ms9405311671463132, createdTime=Fri Aug 28 14:32:25 CST 2020, time=2020-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2112984, encodeId=7559211298436, content=麻烦问下，投了international journal of oncology ，一个多月修回，评审专家意见还可以，但是建议转投oncology reports ，修改后再次投稿，第二天编辑就回复，针对评审专家问题再提了问题，还要了伦理及知情同意，请问这样是不是希望比较大？还会再发给评审专家吗，谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=feb71599658, createdName=woshiliwj, createdTime=Sat Feb 04 11:51:58 CST 2023, time=2023-02-04, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1238680, encodeId=8b1d12386809d, content=6月5号开始投稿，8月12日发邮件暂时接收，后续会发正式接受文件, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a698195230, createdName=ms8000001803522035, createdTime=Sun Aug 14 21:03:07 CST 2022, time=2022-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2146648, encodeId=0ae82146648b0, content=偏重的研究方向：肿瘤 经验分享：请问编辑under review一般持续多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c178590765, createdName=ms5000000683483699, createdTime=Thu Jul 06 17:02:37 CST 2023, time=2023-07-06, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1225866, encodeId=a44a122586627, content=发邮件让修改图片格式，还需要300dpi，单栏8CM，啥意思，是需要我最后以word形式重新投吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a698195230, createdName=ms8000001803522035, createdTime=Sat Jun 11 19:26:55 CST 2022, time=2022-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575460, encodeId=e6cf5e546058, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：3.29投稿 6.27一审结果小修 7.9 further comment 13号接受 26号proof 8.12版面费 8.23early online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=192, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/21/141c3b405ac632875dc5e2f757c9755d.jpg, createdBy=d8912207664, createdName=1085404196_71099776, createdTime=Wed Aug 28 00:00:00 CST 2019, time=2019-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2112386, encodeId=8b21211238696, content=这个杂志2020年被中科院列入预警杂志名单，2021剔除了预警，今天2023.1.31最新，又被剔除出预警名单，这个杂志应该可以放心投稿了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=feb71599658, createdName=woshiliwj, createdTime=Tue Jan 31 14:08:17 CST 2023, time=2023-01-31, status=1, ipAttribution=浙江省)]

2024-08-28 ms6000001003421086 来自四川省

这个杂志我以后不会再投了，前面问你伦理的处理方式，也提供了伦理审查书，包括如何安乐死动物、也没提什么关于伦理的问题，都接收了，快一个月的时候，问你安乐死是符合美国、欧洲、和英国的哪个国家的标准。我写了美国的标准。然后就给拒了，说用异氟烷过量吸入麻醉是不被允许的。你要拒早拒，浪费别人大量的时间

34 0

[GetPortalCommentsPageByObjectIdResponse(id=2222846, encodeId=b6e32222846b5, content=这个杂志我以后不会再投了，前面问你伦理的处理方式，也提供了伦理审查书，包括如何安乐死动物、也没提什么关于伦理的问题，都接收了，快一个月的时候，问你安乐死是符合美国、欧洲、和英国的哪个国家的标准。我写了美国的标准。然后就给拒了，说用异氟烷过量吸入麻醉是不被允许的。你要拒早拒，浪费别人大量的时间, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=286f9158919, createdName=ms6000001003421086, createdTime=Wed Aug 28 15:59:19 CST 2024, time=2024-08-28, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2214074, encodeId=632f22140e45c, content=求问，这个杂志能投case report吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8fe96448100, createdName=ms3000000420360328, createdTime=Tue Jul 09 14:04:30 CST 2024, time=2024-07-09, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2142538, encodeId=f22b214253881, content=投稿命中率:50.0 经验分享：这个杂志的Under review 和Under Review有区别吗，是不是前者是编辑在审后者是外审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=305b1652988, createdName=ms00020231314666, createdTime=Tue Jun 13 10:24:26 CST 2023, time=2023-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=814734, encodeId=cb32814e3446, content=我的文章7.13号under review,现在已经8.29了，突然看见action位置提示replace files，邮箱里找了个遍也没看到通知修改的邮件，大家有知道是什么状况的吗？我都有些毛了，我找了垃圾箱也没有啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=191, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a1921902389, createdName=ms9405311671463132, createdTime=Fri Aug 28 14:32:25 CST 2020, time=2020-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2112984, encodeId=7559211298436, content=麻烦问下，投了international journal of oncology ，一个多月修回，评审专家意见还可以，但是建议转投oncology reports ，修改后再次投稿，第二天编辑就回复，针对评审专家问题再提了问题，还要了伦理及知情同意，请问这样是不是希望比较大？还会再发给评审专家吗，谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=feb71599658, createdName=woshiliwj, createdTime=Sat Feb 04 11:51:58 CST 2023, time=2023-02-04, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1238680, encodeId=8b1d12386809d, content=6月5号开始投稿，8月12日发邮件暂时接收，后续会发正式接受文件, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a698195230, createdName=ms8000001803522035, createdTime=Sun Aug 14 21:03:07 CST 2022, time=2022-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2146648, encodeId=0ae82146648b0, content=偏重的研究方向：肿瘤 经验分享：请问编辑under review一般持续多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c178590765, createdName=ms5000000683483699, createdTime=Thu Jul 06 17:02:37 CST 2023, time=2023-07-06, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1225866, encodeId=a44a122586627, content=发邮件让修改图片格式，还需要300dpi，单栏8CM，啥意思，是需要我最后以word形式重新投吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a698195230, createdName=ms8000001803522035, createdTime=Sat Jun 11 19:26:55 CST 2022, time=2022-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575460, encodeId=e6cf5e546058, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：3.29投稿 6.27一审结果小修 7.9 further comment 13号接受 26号proof 8.12版面费 8.23early online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=192, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/21/141c3b405ac632875dc5e2f757c9755d.jpg, createdBy=d8912207664, createdName=1085404196_71099776, createdTime=Wed Aug 28 00:00:00 CST 2019, time=2019-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2112386, encodeId=8b21211238696, content=这个杂志2020年被中科院列入预警杂志名单，2021剔除了预警，今天2023.1.31最新，又被剔除出预警名单，这个杂志应该可以放心投稿了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=feb71599658, createdName=woshiliwj, createdTime=Tue Jan 31 14:08:17 CST 2023, time=2023-01-31, status=1, ipAttribution=浙江省)]

2024-07-09 ms3000000420360328 来自浙江省

求问，这个杂志能投case report吗？

69 0

[GetPortalCommentsPageByObjectIdResponse(id=2222846, encodeId=b6e32222846b5, content=这个杂志我以后不会再投了，前面问你伦理的处理方式，也提供了伦理审查书，包括如何安乐死动物、也没提什么关于伦理的问题，都接收了，快一个月的时候，问你安乐死是符合美国、欧洲、和英国的哪个国家的标准。我写了美国的标准。然后就给拒了，说用异氟烷过量吸入麻醉是不被允许的。你要拒早拒，浪费别人大量的时间, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=286f9158919, createdName=ms6000001003421086, createdTime=Wed Aug 28 15:59:19 CST 2024, time=2024-08-28, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2214074, encodeId=632f22140e45c, content=求问，这个杂志能投case report吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8fe96448100, createdName=ms3000000420360328, createdTime=Tue Jul 09 14:04:30 CST 2024, time=2024-07-09, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2142538, encodeId=f22b214253881, content=投稿命中率:50.0 经验分享：这个杂志的Under review 和Under Review有区别吗，是不是前者是编辑在审后者是外审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=305b1652988, createdName=ms00020231314666, createdTime=Tue Jun 13 10:24:26 CST 2023, time=2023-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=814734, encodeId=cb32814e3446, content=我的文章7.13号under review,现在已经8.29了，突然看见action位置提示replace files，邮箱里找了个遍也没看到通知修改的邮件，大家有知道是什么状况的吗？我都有些毛了，我找了垃圾箱也没有啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=191, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a1921902389, createdName=ms9405311671463132, createdTime=Fri Aug 28 14:32:25 CST 2020, time=2020-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2112984, encodeId=7559211298436, content=麻烦问下，投了international journal of oncology ，一个多月修回，评审专家意见还可以，但是建议转投oncology reports ，修改后再次投稿，第二天编辑就回复，针对评审专家问题再提了问题，还要了伦理及知情同意，请问这样是不是希望比较大？还会再发给评审专家吗，谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=feb71599658, createdName=woshiliwj, createdTime=Sat Feb 04 11:51:58 CST 2023, time=2023-02-04, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1238680, encodeId=8b1d12386809d, content=6月5号开始投稿，8月12日发邮件暂时接收，后续会发正式接受文件, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a698195230, createdName=ms8000001803522035, createdTime=Sun Aug 14 21:03:07 CST 2022, time=2022-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2146648, encodeId=0ae82146648b0, content=偏重的研究方向：肿瘤 经验分享：请问编辑under review一般持续多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c178590765, createdName=ms5000000683483699, createdTime=Thu Jul 06 17:02:37 CST 2023, time=2023-07-06, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1225866, encodeId=a44a122586627, content=发邮件让修改图片格式，还需要300dpi，单栏8CM，啥意思，是需要我最后以word形式重新投吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a698195230, createdName=ms8000001803522035, createdTime=Sat Jun 11 19:26:55 CST 2022, time=2022-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575460, encodeId=e6cf5e546058, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：3.29投稿 6.27一审结果小修 7.9 further comment 13号接受 26号proof 8.12版面费 8.23early online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=192, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/21/141c3b405ac632875dc5e2f757c9755d.jpg, createdBy=d8912207664, createdName=1085404196_71099776, createdTime=Wed Aug 28 00:00:00 CST 2019, time=2019-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2112386, encodeId=8b21211238696, content=这个杂志2020年被中科院列入预警杂志名单，2021剔除了预警，今天2023.1.31最新，又被剔除出预警名单，这个杂志应该可以放心投稿了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=feb71599658, createdName=woshiliwj, createdTime=Tue Jan 31 14:08:17 CST 2023, time=2023-01-31, status=1, ipAttribution=浙江省)]

2023-06-13 ms00020231314666

投稿命中率:50.0
经验分享：这个杂志的Under review 和Under Review有区别吗，是不是前者是编辑在审后者是外审？

127 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2222846, encodeId=b6e32222846b5, content=这个杂志我以后不会再投了，前面问你伦理的处理方式，也提供了伦理审查书，包括如何安乐死动物、也没提什么关于伦理的问题，都接收了，快一个月的时候，问你安乐死是符合美国、欧洲、和英国的哪个国家的标准。我写了美国的标准。然后就给拒了，说用异氟烷过量吸入麻醉是不被允许的。你要拒早拒，浪费别人大量的时间, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=286f9158919, createdName=ms6000001003421086, createdTime=Wed Aug 28 15:59:19 CST 2024, time=2024-08-28, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2214074, encodeId=632f22140e45c, content=求问，这个杂志能投case report吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8fe96448100, createdName=ms3000000420360328, createdTime=Tue Jul 09 14:04:30 CST 2024, time=2024-07-09, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2142538, encodeId=f22b214253881, content=投稿命中率:50.0 经验分享：这个杂志的Under review 和Under Review有区别吗，是不是前者是编辑在审后者是外审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=305b1652988, createdName=ms00020231314666, createdTime=Tue Jun 13 10:24:26 CST 2023, time=2023-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=814734, encodeId=cb32814e3446, content=我的文章7.13号under review,现在已经8.29了，突然看见action位置提示replace files，邮箱里找了个遍也没看到通知修改的邮件，大家有知道是什么状况的吗？我都有些毛了，我找了垃圾箱也没有啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=191, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a1921902389, createdName=ms9405311671463132, createdTime=Fri Aug 28 14:32:25 CST 2020, time=2020-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2112984, encodeId=7559211298436, content=麻烦问下，投了international journal of oncology ，一个多月修回，评审专家意见还可以，但是建议转投oncology reports ，修改后再次投稿，第二天编辑就回复，针对评审专家问题再提了问题，还要了伦理及知情同意，请问这样是不是希望比较大？还会再发给评审专家吗，谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=feb71599658, createdName=woshiliwj, createdTime=Sat Feb 04 11:51:58 CST 2023, time=2023-02-04, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1238680, encodeId=8b1d12386809d, content=6月5号开始投稿，8月12日发邮件暂时接收，后续会发正式接受文件, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a698195230, createdName=ms8000001803522035, createdTime=Sun Aug 14 21:03:07 CST 2022, time=2022-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2146648, encodeId=0ae82146648b0, content=偏重的研究方向：肿瘤 经验分享：请问编辑under review一般持续多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c178590765, createdName=ms5000000683483699, createdTime=Thu Jul 06 17:02:37 CST 2023, time=2023-07-06, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1225866, encodeId=a44a122586627, content=发邮件让修改图片格式，还需要300dpi，单栏8CM，啥意思，是需要我最后以word形式重新投吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a698195230, createdName=ms8000001803522035, createdTime=Sat Jun 11 19:26:55 CST 2022, time=2022-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575460, encodeId=e6cf5e546058, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：3.29投稿 6.27一审结果小修 7.9 further comment 13号接受 26号proof 8.12版面费 8.23early online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=192, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/21/141c3b405ac632875dc5e2f757c9755d.jpg, createdBy=d8912207664, createdName=1085404196_71099776, createdTime=Wed Aug 28 00:00:00 CST 2019, time=2019-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2112386, encodeId=8b21211238696, content=这个杂志2020年被中科院列入预警杂志名单，2021剔除了预警，今天2023.1.31最新，又被剔除出预警名单，这个杂志应该可以放心投稿了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=feb71599658, createdName=woshiliwj, createdTime=Tue Jan 31 14:08:17 CST 2023, time=2023-01-31, status=1, ipAttribution=浙江省)]

2020-08-28 ms9405311671463132

我的文章7.13号under review,现在已经8.29了，突然看见action位置提示replace files，邮箱里找了个遍也没看到通知修改的邮件，大家有知道是什么状况的吗？我都有些毛了，我找了垃圾箱也没有啊

191 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=2222846, encodeId=b6e32222846b5, content=这个杂志我以后不会再投了，前面问你伦理的处理方式，也提供了伦理审查书，包括如何安乐死动物、也没提什么关于伦理的问题，都接收了，快一个月的时候，问你安乐死是符合美国、欧洲、和英国的哪个国家的标准。我写了美国的标准。然后就给拒了，说用异氟烷过量吸入麻醉是不被允许的。你要拒早拒，浪费别人大量的时间, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=286f9158919, createdName=ms6000001003421086, createdTime=Wed Aug 28 15:59:19 CST 2024, time=2024-08-28, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2214074, encodeId=632f22140e45c, content=求问，这个杂志能投case report吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8fe96448100, createdName=ms3000000420360328, createdTime=Tue Jul 09 14:04:30 CST 2024, time=2024-07-09, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2142538, encodeId=f22b214253881, content=投稿命中率:50.0 经验分享：这个杂志的Under review 和Under Review有区别吗，是不是前者是编辑在审后者是外审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=305b1652988, createdName=ms00020231314666, createdTime=Tue Jun 13 10:24:26 CST 2023, time=2023-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=814734, encodeId=cb32814e3446, content=我的文章7.13号under review,现在已经8.29了，突然看见action位置提示replace files，邮箱里找了个遍也没看到通知修改的邮件，大家有知道是什么状况的吗？我都有些毛了，我找了垃圾箱也没有啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=191, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a1921902389, createdName=ms9405311671463132, createdTime=Fri Aug 28 14:32:25 CST 2020, time=2020-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2112984, encodeId=7559211298436, content=麻烦问下，投了international journal of oncology ，一个多月修回，评审专家意见还可以，但是建议转投oncology reports ，修改后再次投稿，第二天编辑就回复，针对评审专家问题再提了问题，还要了伦理及知情同意，请问这样是不是希望比较大？还会再发给评审专家吗，谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=feb71599658, createdName=woshiliwj, createdTime=Sat Feb 04 11:51:58 CST 2023, time=2023-02-04, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1238680, encodeId=8b1d12386809d, content=6月5号开始投稿，8月12日发邮件暂时接收，后续会发正式接受文件, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a698195230, createdName=ms8000001803522035, createdTime=Sun Aug 14 21:03:07 CST 2022, time=2022-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2146648, encodeId=0ae82146648b0, content=偏重的研究方向：肿瘤 经验分享：请问编辑under review一般持续多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c178590765, createdName=ms5000000683483699, createdTime=Thu Jul 06 17:02:37 CST 2023, time=2023-07-06, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1225866, encodeId=a44a122586627, content=发邮件让修改图片格式，还需要300dpi，单栏8CM，啥意思，是需要我最后以word形式重新投吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a698195230, createdName=ms8000001803522035, createdTime=Sat Jun 11 19:26:55 CST 2022, time=2022-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575460, encodeId=e6cf5e546058, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：3.29投稿 6.27一审结果小修 7.9 further comment 13号接受 26号proof 8.12版面费 8.23early online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=192, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/21/141c3b405ac632875dc5e2f757c9755d.jpg, createdBy=d8912207664, createdName=1085404196_71099776, createdTime=Wed Aug 28 00:00:00 CST 2019, time=2019-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2112386, encodeId=8b21211238696, content=这个杂志2020年被中科院列入预警杂志名单，2021剔除了预警，今天2023.1.31最新，又被剔除出预警名单，这个杂志应该可以放心投稿了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=feb71599658, createdName=woshiliwj, createdTime=Tue Jan 31 14:08:17 CST 2023, time=2023-01-31, status=1, ipAttribution=浙江省)]

2023-02-04 woshiliwj 来自浙江省

麻烦问下，投了international journal of oncology ，一个多月修回，评审专家意见还可以，但是建议转投oncology reports ，修改后再次投稿，第二天编辑就回复，针对评审专家问题再提了问题，还要了伦理及知情同意，请问这样是不是希望比较大？还会再发给评审专家吗，谢谢

0 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2222846, encodeId=b6e32222846b5, content=这个杂志我以后不会再投了，前面问你伦理的处理方式，也提供了伦理审查书，包括如何安乐死动物、也没提什么关于伦理的问题，都接收了，快一个月的时候，问你安乐死是符合美国、欧洲、和英国的哪个国家的标准。我写了美国的标准。然后就给拒了，说用异氟烷过量吸入麻醉是不被允许的。你要拒早拒，浪费别人大量的时间, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=286f9158919, createdName=ms6000001003421086, createdTime=Wed Aug 28 15:59:19 CST 2024, time=2024-08-28, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2214074, encodeId=632f22140e45c, content=求问，这个杂志能投case report吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8fe96448100, createdName=ms3000000420360328, createdTime=Tue Jul 09 14:04:30 CST 2024, time=2024-07-09, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2142538, encodeId=f22b214253881, content=投稿命中率:50.0 经验分享：这个杂志的Under review 和Under Review有区别吗，是不是前者是编辑在审后者是外审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=305b1652988, createdName=ms00020231314666, createdTime=Tue Jun 13 10:24:26 CST 2023, time=2023-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=814734, encodeId=cb32814e3446, content=我的文章7.13号under review,现在已经8.29了，突然看见action位置提示replace files，邮箱里找了个遍也没看到通知修改的邮件，大家有知道是什么状况的吗？我都有些毛了，我找了垃圾箱也没有啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=191, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a1921902389, createdName=ms9405311671463132, createdTime=Fri Aug 28 14:32:25 CST 2020, time=2020-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2112984, encodeId=7559211298436, content=麻烦问下，投了international journal of oncology ，一个多月修回，评审专家意见还可以，但是建议转投oncology reports ，修改后再次投稿，第二天编辑就回复，针对评审专家问题再提了问题，还要了伦理及知情同意，请问这样是不是希望比较大？还会再发给评审专家吗，谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=feb71599658, createdName=woshiliwj, createdTime=Sat Feb 04 11:51:58 CST 2023, time=2023-02-04, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1238680, encodeId=8b1d12386809d, content=6月5号开始投稿，8月12日发邮件暂时接收，后续会发正式接受文件, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a698195230, createdName=ms8000001803522035, createdTime=Sun Aug 14 21:03:07 CST 2022, time=2022-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2146648, encodeId=0ae82146648b0, content=偏重的研究方向：肿瘤 经验分享：请问编辑under review一般持续多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c178590765, createdName=ms5000000683483699, createdTime=Thu Jul 06 17:02:37 CST 2023, time=2023-07-06, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1225866, encodeId=a44a122586627, content=发邮件让修改图片格式，还需要300dpi，单栏8CM，啥意思，是需要我最后以word形式重新投吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a698195230, createdName=ms8000001803522035, createdTime=Sat Jun 11 19:26:55 CST 2022, time=2022-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575460, encodeId=e6cf5e546058, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：3.29投稿 6.27一审结果小修 7.9 further comment 13号接受 26号proof 8.12版面费 8.23early online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=192, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/21/141c3b405ac632875dc5e2f757c9755d.jpg, createdBy=d8912207664, createdName=1085404196_71099776, createdTime=Wed Aug 28 00:00:00 CST 2019, time=2019-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2112386, encodeId=8b21211238696, content=这个杂志2020年被中科院列入预警杂志名单，2021剔除了预警，今天2023.1.31最新，又被剔除出预警名单，这个杂志应该可以放心投稿了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=feb71599658, createdName=woshiliwj, createdTime=Tue Jan 31 14:08:17 CST 2023, time=2023-01-31, status=1, ipAttribution=浙江省)]

2022-08-14 ms8000001803522035

6月5号开始投稿，8月12日发邮件暂时接收，后续会发正式接受文件

135 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2222846, encodeId=b6e32222846b5, content=这个杂志我以后不会再投了，前面问你伦理的处理方式，也提供了伦理审查书，包括如何安乐死动物、也没提什么关于伦理的问题，都接收了，快一个月的时候，问你安乐死是符合美国、欧洲、和英国的哪个国家的标准。我写了美国的标准。然后就给拒了，说用异氟烷过量吸入麻醉是不被允许的。你要拒早拒，浪费别人大量的时间, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=286f9158919, createdName=ms6000001003421086, createdTime=Wed Aug 28 15:59:19 CST 2024, time=2024-08-28, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2214074, encodeId=632f22140e45c, content=求问，这个杂志能投case report吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8fe96448100, createdName=ms3000000420360328, createdTime=Tue Jul 09 14:04:30 CST 2024, time=2024-07-09, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2142538, encodeId=f22b214253881, content=投稿命中率:50.0 经验分享：这个杂志的Under review 和Under Review有区别吗，是不是前者是编辑在审后者是外审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=305b1652988, createdName=ms00020231314666, createdTime=Tue Jun 13 10:24:26 CST 2023, time=2023-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=814734, encodeId=cb32814e3446, content=我的文章7.13号under review,现在已经8.29了，突然看见action位置提示replace files，邮箱里找了个遍也没看到通知修改的邮件，大家有知道是什么状况的吗？我都有些毛了，我找了垃圾箱也没有啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=191, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a1921902389, createdName=ms9405311671463132, createdTime=Fri Aug 28 14:32:25 CST 2020, time=2020-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2112984, encodeId=7559211298436, content=麻烦问下，投了international journal of oncology ，一个多月修回，评审专家意见还可以，但是建议转投oncology reports ，修改后再次投稿，第二天编辑就回复，针对评审专家问题再提了问题，还要了伦理及知情同意，请问这样是不是希望比较大？还会再发给评审专家吗，谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=feb71599658, createdName=woshiliwj, createdTime=Sat Feb 04 11:51:58 CST 2023, time=2023-02-04, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1238680, encodeId=8b1d12386809d, content=6月5号开始投稿，8月12日发邮件暂时接收，后续会发正式接受文件, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a698195230, createdName=ms8000001803522035, createdTime=Sun Aug 14 21:03:07 CST 2022, time=2022-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2146648, encodeId=0ae82146648b0, content=偏重的研究方向：肿瘤 经验分享：请问编辑under review一般持续多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c178590765, createdName=ms5000000683483699, createdTime=Thu Jul 06 17:02:37 CST 2023, time=2023-07-06, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1225866, encodeId=a44a122586627, content=发邮件让修改图片格式，还需要300dpi，单栏8CM，啥意思，是需要我最后以word形式重新投吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a698195230, createdName=ms8000001803522035, createdTime=Sat Jun 11 19:26:55 CST 2022, time=2022-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575460, encodeId=e6cf5e546058, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：3.29投稿 6.27一审结果小修 7.9 further comment 13号接受 26号proof 8.12版面费 8.23early online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=192, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/21/141c3b405ac632875dc5e2f757c9755d.jpg, createdBy=d8912207664, createdName=1085404196_71099776, createdTime=Wed Aug 28 00:00:00 CST 2019, time=2019-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2112386, encodeId=8b21211238696, content=这个杂志2020年被中科院列入预警杂志名单，2021剔除了预警，今天2023.1.31最新，又被剔除出预警名单，这个杂志应该可以放心投稿了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=feb71599658, createdName=woshiliwj, createdTime=Tue Jan 31 14:08:17 CST 2023, time=2023-01-31, status=1, ipAttribution=浙江省)]

2023-07-06 ms5000000683483699 来自山东省

偏重的研究方向：肿瘤
经验分享：请问编辑under review一般持续多久呀

136 0

[GetPortalCommentsPageByObjectIdResponse(id=2222846, encodeId=b6e32222846b5, content=这个杂志我以后不会再投了，前面问你伦理的处理方式，也提供了伦理审查书，包括如何安乐死动物、也没提什么关于伦理的问题，都接收了，快一个月的时候，问你安乐死是符合美国、欧洲、和英国的哪个国家的标准。我写了美国的标准。然后就给拒了，说用异氟烷过量吸入麻醉是不被允许的。你要拒早拒，浪费别人大量的时间, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=286f9158919, createdName=ms6000001003421086, createdTime=Wed Aug 28 15:59:19 CST 2024, time=2024-08-28, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2214074, encodeId=632f22140e45c, content=求问，这个杂志能投case report吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8fe96448100, createdName=ms3000000420360328, createdTime=Tue Jul 09 14:04:30 CST 2024, time=2024-07-09, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2142538, encodeId=f22b214253881, content=投稿命中率:50.0 经验分享：这个杂志的Under review 和Under Review有区别吗，是不是前者是编辑在审后者是外审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=305b1652988, createdName=ms00020231314666, createdTime=Tue Jun 13 10:24:26 CST 2023, time=2023-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=814734, encodeId=cb32814e3446, content=我的文章7.13号under review,现在已经8.29了，突然看见action位置提示replace files，邮箱里找了个遍也没看到通知修改的邮件，大家有知道是什么状况的吗？我都有些毛了，我找了垃圾箱也没有啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=191, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a1921902389, createdName=ms9405311671463132, createdTime=Fri Aug 28 14:32:25 CST 2020, time=2020-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2112984, encodeId=7559211298436, content=麻烦问下，投了international journal of oncology ，一个多月修回，评审专家意见还可以，但是建议转投oncology reports ，修改后再次投稿，第二天编辑就回复，针对评审专家问题再提了问题，还要了伦理及知情同意，请问这样是不是希望比较大？还会再发给评审专家吗，谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=feb71599658, createdName=woshiliwj, createdTime=Sat Feb 04 11:51:58 CST 2023, time=2023-02-04, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1238680, encodeId=8b1d12386809d, content=6月5号开始投稿，8月12日发邮件暂时接收，后续会发正式接受文件, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a698195230, createdName=ms8000001803522035, createdTime=Sun Aug 14 21:03:07 CST 2022, time=2022-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2146648, encodeId=0ae82146648b0, content=偏重的研究方向：肿瘤 经验分享：请问编辑under review一般持续多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c178590765, createdName=ms5000000683483699, createdTime=Thu Jul 06 17:02:37 CST 2023, time=2023-07-06, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1225866, encodeId=a44a122586627, content=发邮件让修改图片格式，还需要300dpi，单栏8CM，啥意思，是需要我最后以word形式重新投吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a698195230, createdName=ms8000001803522035, createdTime=Sat Jun 11 19:26:55 CST 2022, time=2022-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575460, encodeId=e6cf5e546058, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：3.29投稿 6.27一审结果小修 7.9 further comment 13号接受 26号proof 8.12版面费 8.23early online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=192, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/21/141c3b405ac632875dc5e2f757c9755d.jpg, createdBy=d8912207664, createdName=1085404196_71099776, createdTime=Wed Aug 28 00:00:00 CST 2019, time=2019-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2112386, encodeId=8b21211238696, content=这个杂志2020年被中科院列入预警杂志名单，2021剔除了预警，今天2023.1.31最新，又被剔除出预警名单，这个杂志应该可以放心投稿了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=feb71599658, createdName=woshiliwj, createdTime=Tue Jan 31 14:08:17 CST 2023, time=2023-01-31, status=1, ipAttribution=浙江省)]

2022-06-11 ms8000001803522035

发邮件让修改图片格式，还需要300dpi，单栏8CM，啥意思，是需要我最后以word形式重新投吗？

125 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2222846, encodeId=b6e32222846b5, content=这个杂志我以后不会再投了，前面问你伦理的处理方式，也提供了伦理审查书，包括如何安乐死动物、也没提什么关于伦理的问题，都接收了，快一个月的时候，问你安乐死是符合美国、欧洲、和英国的哪个国家的标准。我写了美国的标准。然后就给拒了，说用异氟烷过量吸入麻醉是不被允许的。你要拒早拒，浪费别人大量的时间, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=286f9158919, createdName=ms6000001003421086, createdTime=Wed Aug 28 15:59:19 CST 2024, time=2024-08-28, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2214074, encodeId=632f22140e45c, content=求问，这个杂志能投case report吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8fe96448100, createdName=ms3000000420360328, createdTime=Tue Jul 09 14:04:30 CST 2024, time=2024-07-09, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2142538, encodeId=f22b214253881, content=投稿命中率:50.0 经验分享：这个杂志的Under review 和Under Review有区别吗，是不是前者是编辑在审后者是外审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=305b1652988, createdName=ms00020231314666, createdTime=Tue Jun 13 10:24:26 CST 2023, time=2023-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=814734, encodeId=cb32814e3446, content=我的文章7.13号under review,现在已经8.29了，突然看见action位置提示replace files，邮箱里找了个遍也没看到通知修改的邮件，大家有知道是什么状况的吗？我都有些毛了，我找了垃圾箱也没有啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=191, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a1921902389, createdName=ms9405311671463132, createdTime=Fri Aug 28 14:32:25 CST 2020, time=2020-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2112984, encodeId=7559211298436, content=麻烦问下，投了international journal of oncology ，一个多月修回，评审专家意见还可以，但是建议转投oncology reports ，修改后再次投稿，第二天编辑就回复，针对评审专家问题再提了问题，还要了伦理及知情同意，请问这样是不是希望比较大？还会再发给评审专家吗，谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=feb71599658, createdName=woshiliwj, createdTime=Sat Feb 04 11:51:58 CST 2023, time=2023-02-04, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1238680, encodeId=8b1d12386809d, content=6月5号开始投稿，8月12日发邮件暂时接收，后续会发正式接受文件, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a698195230, createdName=ms8000001803522035, createdTime=Sun Aug 14 21:03:07 CST 2022, time=2022-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2146648, encodeId=0ae82146648b0, content=偏重的研究方向：肿瘤 经验分享：请问编辑under review一般持续多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c178590765, createdName=ms5000000683483699, createdTime=Thu Jul 06 17:02:37 CST 2023, time=2023-07-06, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1225866, encodeId=a44a122586627, content=发邮件让修改图片格式，还需要300dpi，单栏8CM，啥意思，是需要我最后以word形式重新投吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a698195230, createdName=ms8000001803522035, createdTime=Sat Jun 11 19:26:55 CST 2022, time=2022-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575460, encodeId=e6cf5e546058, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：3.29投稿 6.27一审结果小修 7.9 further comment 13号接受 26号proof 8.12版面费 8.23early online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=192, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/21/141c3b405ac632875dc5e2f757c9755d.jpg, createdBy=d8912207664, createdName=1085404196_71099776, createdTime=Wed Aug 28 00:00:00 CST 2019, time=2019-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2112386, encodeId=8b21211238696, content=这个杂志2020年被中科院列入预警杂志名单，2021剔除了预警，今天2023.1.31最新，又被剔除出预警名单，这个杂志应该可以放心投稿了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=feb71599658, createdName=woshiliwj, createdTime=Tue Jan 31 14:08:17 CST 2023, time=2023-01-31, status=1, ipAttribution=浙江省)]

2019-08-28 1085404196_71099776

审稿速度:3.0 | 投稿命中率:50.0
经验分享：3.29投稿 6.27一审结果小修 7.9 further comment 13号接受 26号proof 8.12版面费 8.23early online

192 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2222846, encodeId=b6e32222846b5, content=这个杂志我以后不会再投了，前面问你伦理的处理方式，也提供了伦理审查书，包括如何安乐死动物、也没提什么关于伦理的问题，都接收了，快一个月的时候，问你安乐死是符合美国、欧洲、和英国的哪个国家的标准。我写了美国的标准。然后就给拒了，说用异氟烷过量吸入麻醉是不被允许的。你要拒早拒，浪费别人大量的时间, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=286f9158919, createdName=ms6000001003421086, createdTime=Wed Aug 28 15:59:19 CST 2024, time=2024-08-28, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2214074, encodeId=632f22140e45c, content=求问，这个杂志能投case report吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8fe96448100, createdName=ms3000000420360328, createdTime=Tue Jul 09 14:04:30 CST 2024, time=2024-07-09, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2142538, encodeId=f22b214253881, content=投稿命中率:50.0 经验分享：这个杂志的Under review 和Under Review有区别吗，是不是前者是编辑在审后者是外审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=305b1652988, createdName=ms00020231314666, createdTime=Tue Jun 13 10:24:26 CST 2023, time=2023-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=814734, encodeId=cb32814e3446, content=我的文章7.13号under review,现在已经8.29了，突然看见action位置提示replace files，邮箱里找了个遍也没看到通知修改的邮件，大家有知道是什么状况的吗？我都有些毛了，我找了垃圾箱也没有啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=191, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a1921902389, createdName=ms9405311671463132, createdTime=Fri Aug 28 14:32:25 CST 2020, time=2020-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2112984, encodeId=7559211298436, content=麻烦问下，投了international journal of oncology ，一个多月修回，评审专家意见还可以，但是建议转投oncology reports ，修改后再次投稿，第二天编辑就回复，针对评审专家问题再提了问题，还要了伦理及知情同意，请问这样是不是希望比较大？还会再发给评审专家吗，谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=feb71599658, createdName=woshiliwj, createdTime=Sat Feb 04 11:51:58 CST 2023, time=2023-02-04, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1238680, encodeId=8b1d12386809d, content=6月5号开始投稿，8月12日发邮件暂时接收，后续会发正式接受文件, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a698195230, createdName=ms8000001803522035, createdTime=Sun Aug 14 21:03:07 CST 2022, time=2022-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2146648, encodeId=0ae82146648b0, content=偏重的研究方向：肿瘤 经验分享：请问编辑under review一般持续多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c178590765, createdName=ms5000000683483699, createdTime=Thu Jul 06 17:02:37 CST 2023, time=2023-07-06, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1225866, encodeId=a44a122586627, content=发邮件让修改图片格式，还需要300dpi，单栏8CM，啥意思，是需要我最后以word形式重新投吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a698195230, createdName=ms8000001803522035, createdTime=Sat Jun 11 19:26:55 CST 2022, time=2022-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575460, encodeId=e6cf5e546058, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：3.29投稿 6.27一审结果小修 7.9 further comment 13号接受 26号proof 8.12版面费 8.23early online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=192, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/21/141c3b405ac632875dc5e2f757c9755d.jpg, createdBy=d8912207664, createdName=1085404196_71099776, createdTime=Wed Aug 28 00:00:00 CST 2019, time=2019-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2112386, encodeId=8b21211238696, content=这个杂志2020年被中科院列入预警杂志名单，2021剔除了预警，今天2023.1.31最新，又被剔除出预警名单，这个杂志应该可以放心投稿了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=feb71599658, createdName=woshiliwj, createdTime=Tue Jan 31 14:08:17 CST 2023, time=2023-01-31, status=1, ipAttribution=浙江省)]

2023-01-31 woshiliwj 来自浙江省

这个杂志2020年被中科院列入预警杂志名单，2021剔除了预警，今天2023.1.31最新，又被剔除出预警名单，这个杂志应该可以放心投稿了吗？

116 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务